This further underlines that the potent weight-reducing benefits of the bimodal compound are not linked to an aggravated adverse profile when compared to marketed incretin-based drugs such as semaglutide
Mounjaro is a weekly injectable weight-loss drug for adults with obesity or overweight plus another weight-related condition
or a BMI between 27 and 30 and at least one weight-related comorbidity
Segn Mnica Katz, el gasto asociado a esta problemtica y sus complicaciones ya compromete ms del 2,5% del PBI
Versions of these new drugs were approved for type 2 diabetes as well, but it was their weight-loss effects that stole the spotlight
The special conditions of HE in acute liver failure (ALF) and acute-on-chronic liver failure (ACLF) were included, as well as the specific care in patients with HE: medications to avoid, analgesics that can and cannot be used, and types of sedation that can be used in procedures and those that cannot